21.54
Caredx Inc Aktie (CDNA) Neueste Nachrichten
CDNA Technical Analysis & Stock Price Forecast - Intellectia AI
CareDx to Participate in Upcoming June 2026 Investor Conferences - BioSpace
CareDx plans June talks at Jefferies and Goldman Sachs healthcare events - Stock Titan
CareDx to Participate in Upcoming Investor Conferences - The Joplin Globe
CareDx Earnings Call: Growth, Navaris Deal and Pivot - TipRanks
Precision Trading with Caredx Inc. (CDNA) Risk Zones - Stock Traders Daily
Insider Sell Alert: Arthur Torres Sells Shares of CareDx Inc (CD - GuruFocus
CareDx director Arthur Torres sells $214,675 in company stock By Investing.com - Investing.com Nigeria
CareDx director Arthur Torres sells $214,675 in company stock - Investing.com
CareDx (CDNA) director sells 10,570 shares in open-market trades - Stock Titan
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's CareDx Inc(CDNA) Holding History - GuruFocus
ETFs Investing in CareDx, Inc. Stocks - TradingView
Rule 144 notice and recent sale by insider (CDNA) - Stock Titan
CareDx Lawsuit Resolution Refocuses Attention On Valuation And Growth Prospects - Sahm
[144] CareDx, Inc. SEC Filing - Stock Titan
CareDx expands HeartCare platform to transform post transplant care for heart recipients - Traders Union
How Investors Are Reacting To CareDx (CDNA) Profit Return, Higher 2026 Outlook And New Shelf Registration - Sahm
CareDx (CDNA) Successfully Resolves Legal Action - GuruFocus
Caredx announces dismissal of 2021 qui tam suit - marketscreener.com
CareDx(CDNA) Stock Options Chain | Quotes & News - Moomoo
CareDx Announces Dismissal of 2021 Qui Tam Suit - marketscreener.com
Earnings Preview: CareDx to Report Financial Results Post-market on April 28 - Moomoo
Technical Reactions to CDNA Trends in Macro Strategies - Stock Traders Daily
Insider Sell: Jeffrey Novack Sells 2,688 Shares of CareDx Inc (C - GuruFocus
CareDx (NASDAQ: CDNA) counsel's 2,688-share sale under 10b5-1 - Stock Titan
CareDx (CDNA) Q1 2026 Earnings Call Transcript - AOL.com
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The National Law Review
A Look At CareDx (CDNA) Valuation After Recent Share Price Momentum Cools - Yahoo Finance
CareDx (CDNA) General Counsel has 2,873 shares withheld to cover RSU taxes - Stock Titan
How Investors Are Reacting To CareDx (CDNA) Profitability Milestone And Higher 2026 Revenue Guidance - Sahm
CareDx (NASDAQ:CDNA) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
MSN Money - MSN
23 new CareDx hires receive 63,856 stock units under Nasdaq rule - Stock Titan
CareDx sharpens focus on core testing services - MSN
CareDx (CDNA) Q2 2025 Earnings Transcript - AOL.com
CareDx : 2025 Annual Report - marketscreener.com
CareDx : 2026 Proxy Statement - marketscreener.com
CDNA SEC FilingsCaredx 10-K, 10-Q, 8-K Forms - Stock Titan
Analysts Conflicted on These Healthcare Names: CareDx (CDNA), Biogen (BIIB) and Guardant Health (GH) - The Globe and Mail
H.C. Wainwright reiterates Neutral rating on CareDx stock By Investing.com - Investing.com Australia
H.C. Wainwright reiterates Neutral rating on CareDx stock - Investing.com
Analysts Offer Insights on Healthcare Companies: Janux Therapeutics Inc (JANX), Stryker (SYK) and CareDx (CDNA) - The Globe and Mail
CareDx Acquires Navaris and Divests Lab Products to Accelerate Growth - HarianBasis.co
Analysts Offer Insights on Healthcare Companies: CareDx (CDNA) and Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
CareDx Deadline Alert - TMX Newsfile
CareDx Earnings Call: Growth Accelerates Amid Bold Pivot - TipRanks
CareDx Announces Agreement to Acquire Naveris, A Leader in Viral-Mediated Cancer MRD Surveillance Testing - The National Law Review
Q1 2026 Presentation (04/28/2026 00: 00 - marketscreener.com
CareDx (NASDAQ:CDNA) Trading Down 8.7%What's Next? - MarketBeat
CareDx sharpens precision medicine focus with $260m Naveris acquisition - Yahoo Finance
Caredx to acquire Naveris for up to $260 million - BioWorld News
CareDx : ESG Report (CareDx 2026 ESG Report) - marketscreener.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):